When ccRCCs are stratified by their SETD2 mutation status, we observe that expression of OCT2, PRRX1, and SOX2 is higher in SETD2 mutant compared to WT ccRCC (Fig. S8C), consistent with findings in the RPTEC model. This evidence concerns the gene PRRX1 and nonpapillary renal cell carcinoma.